Diagnostic and treatment concerns in familial Mediterranean fever

Bailliere's Best Practice and Research in Clinical Rheumatology

Volumn 14, Issue 3, 2000, Pages 477-498

  Livneh, Avi ^a   Langevitz, Pnina ^a  

^a HELLER INSTITUTE OF MEDICAL RESEARCH   (Israel)

Author keywords

Amyloidosis; Colchicine; Diagnostic criteria; Familial Mediterranean fever; Periodic febrile syndromes

Indexed keywords

ALPHA INTERFERON; ANALGESIC AGENT; ANTIINFLAMMATORY AGENT; COLCHICINE; CYCLOSPORIN; DICLOFENAC; ETANERCEPT;

ARTHRALGIA; AUTOSOMAL RECESSIVE INHERITANCE; CHRONIC ARTHRITIS; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; FAMILIAL MEDITERRANEAN FEVER; GASTROINTESTINAL DISEASE; GENE MUTATION; HEMATOLOGIC DISEASE; HUMAN; KIDNEY AMYLOIDOSIS; LIVER INJURY; MYALGIA; MYOPATHY; NEUROPATHY; OLIGOSPERMIA; PRIORITY JOURNAL; REVIEW; SCROTUM DISORDER; SKIN DISEASE; THORAX PAIN; TREATMENT PLANNING; VASCULITIS;

EID: 0033797615     PISSN: 15216942     EISSN: None     Source Type: Journal    
DOI: 10.1053/berh.2000.0089     Document Type: Article

References (68)

1. Familial Mediterranean fever. A survey of 470 cases and review of the literature
2. Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever
3. A candidate gene for familial Mediterranean fever
4. Non-founder mutations in the MEFV gene establish this gene as the cause of familial Mediterranean fever (FMF)
5. Pyrin/marenostrin mutations in familial Mediterranean fever
6. Familial Mediterranean fever at the Millennium. Clinical spectrum, ancient mutations and survey of 100 American referrals to the National Institute of Health
7. MEFV mutation analysis in patients suffering from amyloidosis of familial Mediterranean fever
8. Phenotype-genotype correlation in Jewish patients suffering from familial Mediterranean fever (FMF)
9. The changing face of familial Mediterranean fever
10. Activation of the cytokine network in familial Mediterranean fever
11. Plasma fibrinogen in familial Mediterranean fever
12. Significant delay in diagnosis of patients with familial Mediterranean fever
13. Elective laparoscopic appendectomy in patients with familial Mediterranean fever
14. Criteria for the diagnosis of familial Mediterranean fever
15. Familial Mediterranean fever in Armenians. Analysis of 100 cases
16. The arthritis of familial Mediterranean fever (FMF)
17. Seronegative spondyloarthropathy in familial Mediterranean fever
18. Schonlein-Henoch syndrome in patients with familial Mediterranean fever
19. SLE in patients with familial Mediterranean fever (FMF)
20. Criteria for diagnosis of Behcet's disease
21. Increased prevelance of joint manifestations in patients with recurrent aphthous stomatitis (RAS)
22. Undifferentiated spondyloarthropathies
23. Attacks of pericarditis as a manifestation of familial Mediterranean fever (FMF)
24. Familial Mediterranean fever presenting with massive cardiac tamponade
25. Clinical spectrum of familial Hibernian fever: A 14-year follow-up study of the index case and extended family
26. Erysipelas-like erythema of familial Mediterranean fever: Clinical pathological correlation
27. The cutaneous manifestations in children with familial Mediterranean fever (recurrent hereditary polyserositis). A six-year study
28. Acute orchitis in familial Mediterranean fever
29. Acute scrotal pain complicating familial Mediterranean fever in children
30. The role of amyloidosis in familial Mediterranean fever. A population study
31. Phenotype-genotype correlation in familial Mediterranean fever: Evidence for an association between Met694Val and amyloidosis
32. Familial Mediterranean fever in children: Report of a large series and discussion of the risk and prognostic factors of amyloidosis
33. Variable incidence of amyloidosis in familial Mediterranean fever among different ethnic groups
34. Abdominal fat tissue aspirate in amyloidosis of familial Mediterranean fever
35. Protracted arthritis in familial Mediterranean fever
36. Chronic massive knee effusion in familial Mediterranean fever
37. Intestinal strangulation complicating familial Mediterranean fever (FMF)
38. Restaurant episodes of acute scrotum with ischemic testicular necrosis in a patient with familial Mediterranean fever
39. Constrictive pericarditis in familial Mediterranean fever
40. Pulmonary associations in familial Mediterranean fever
41. Protracted febrile myalgia in patients with familial Mediterranean fever
42. Polyarteritis nodosa and familial Mediterranean fever: A report of 2 cases and review of the literature
43. Behcet's disease in familial Mediterranean fever. Characterization of the association between the two diseases
44. Spectrum of renal involvement in familial Mediterranean fever
45. Vasculitis in familial Mediterranean fever
46. Fibromyalgia in familial Mediterranean fever
47. Quality of life of patients with familial Mediterranean fever
48. Mutation and haplotype studies of familial Mediterranean fever reveal new ancestral relationships and evidence for high carrier frequency with reduced penetrance in the Ashkenazi Jewish population
49. MEFV-gene analysis in Armenian patients with familial Mediterranean fever: Diagnostic value and unfavorable renal prognosis of the M694V homozygous genotype - genetic and therapeutic implications
50. Assessment of pyrin gene mutations in Turks with familial Mediterranean fever
51. Hyperimmunoglobulinemia D and periodic fever. The clinical spectrum in a series of 50 patients
52. Mutations in the gene encoding mevalonate kinase cause hyper-IgD and periodic fever syndrome
53. Familial Mediterranean fever and hyperimmunoglobulinemia D syndrome: 2 diseases with distinct clinical, serologic and genetic features
54. Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFRI, define a family of dominantly inherited autoinflammatory syndromes
55. Syndrome of periodic fever pharyngitis and aphthous stomatitis
56. Periodic fever, aphthous stomatitis, pharyngitis and adenopathy syndrome: Clinical characteristics and outcome
57. Behcet's disease. Report of 41 cases and review of the literature
58. Colchicine prophylaxis in familial Mediterranean fever reappraisal after 15 years
59. The efficacy of interferon alpha on colchicine-resistant familial Mediterranean fever attacks: A pilot study
60. Colchicine in the prevention and treatment of the amyloidosis of familial Mediterranean fever
61. Colchicine treatment of AA amyloidosis of familial Mediterranean fever. An analysis of factors affecting outcome
62. Colchicine prevents kidney transplant amyloidosis in familial Mediterranean fever
63. Cyclosporine toxicity in amyloidotic patients
64. Survival and outcome of FMF amyloidotic patients post renal transplantation
65. Colchicine: 1998 update
66. The causes of sterility in females with familial Mediterranean fever
67. Colchicine treatment in conception and pregnancy: Two hundred thirty-one pregnancies in patients with familial Mediterranean fever
68. Colchicine inhibition of serum amyloid protein SAA and SAP synthesis in primary mouse liver cell cultures